Ozempic
- Product NDC
- 50090-5949
- 11-digit product format
- 500905949
- Labeler code
- 50090
- Product ID
- 50090-5949_a5c23c93-1c61-4768-b7f2-1e430cd21a8d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- semaglutide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- A-S Medication Solutions
- Application
- NDA209637
- Marketing category
- NDA
- Marketing start
- 2020-09-30
- Substance
- SEMAGLUTIDE
- Active strength
- 1.34 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ozempic
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SEMAGLUTIDE | 1.34 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 53AXN4NNHX |
| Rxcui | 2398841, 2398842 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5949-0 | Ozempic | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | | 3 |
| 50090-5949-0 | Ozempic | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5949 | OZEMPIC (SEMAGLUTIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 2 package rows | 20231123_979e4df4-0597-48ea-b51c-0f699fa6d166.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5949-0 | 50090594900 | 1 SYRINGE, PLASTIC in 1 CARTON (50090-5949-0) / 3 mL in 1 SYRINGE, PLASTIC | 2022-04-01 | 0000-00-00 | No | No | Current |